Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
NCT01949766
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class
Conditions
Byler Disease
Interventions
DRUG:
Glycerol phenylbutyrate
Sponsor
University of Pittsburgh